Literature DB >> 2413859

Steroid binding protein(s) in yeasts.

M Das, A Datta.   

Abstract

A progesterone binding protein has been detected in the cytosol prepared from glucose grown cells of both Candida albicans and Saccharomyces cerevisiae. The specific activity of this binding protein is much higher in C. albicans, a pathogenic yeast as compared to the non-pathogenic yeast S. cerevisiae.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413859

Source DB:  PubMed          Journal:  Biochem Int        ISSN: 0158-5231


  6 in total

1.  Recognition of binding sites on Candida albicans by monoclonal antibodies to human leukocyte antigens.

Authors:  C L Mayer; R D Diamond; J E Edwards
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  Responses of pathogenic and nonpathogenic yeast species to steroids reveal the functioning and evolution of multidrug resistance transcriptional networks.

Authors:  Dibyendu Banerjee; Gaelle Lelandais; Sudhanshu Shukla; Gauranga Mukhopadhyay; Claude Jacq; Frederic Devaux; Rajendra Prasad
Journal:  Eukaryot Cell       Date:  2007-11-09

3.  A genome-wide steroid response study of the major human fungal pathogen Candida albicans.

Authors:  Dibyendu Banerjee; Nuria Martin; Soumyadeep Nandi; Sudhanshu Shukla; Angel Dominguez; Gauranga Mukhopadhyay; Rajendra Prasad
Journal:  Mycopathologia       Date:  2007-06-16       Impact factor: 2.574

4.  Characterization and ligand identification of a membrane progesterone receptor in fungi: existence of a novel PAQR in Sporothrix schenckii.

Authors:  Waleska Gonzalez-Velazquez; Ricardo Gonzalez-Mendez; Nuri Rodriguez-del Valle
Journal:  BMC Microbiol       Date:  2012-09-07       Impact factor: 3.605

Review 5.  Novel Regulatory Mechanisms of Pathogenicity and Virulence to Combat MDR in Candida albicans.

Authors:  Saif Hameed; Zeeshan Fatima
Journal:  Int J Microbiol       Date:  2013-09-16

Review 6.  Efflux pump proteins in antifungal resistance.

Authors:  Rajendra Prasad; Manpreet K Rawal
Journal:  Front Pharmacol       Date:  2014-08-29       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.